Share |
Press Releases 2012
December 28, 2012 at 11:40 pm

Verisante Issues Stock Options


VANCOUVER, BRITISH COLUMBIA - Verisante Technology, Inc. (TSX-V: VRS, OTCQX: VRSEF) (the “Company” or “Verisante”), a leader in cancer detection technology, announced that, subject to the approval of the TSX Venture Exchange, a total of 675,000 stock options were issued to Directors and Officers of the Company on the...

Full story

December 20, 2012 at 2:00 pm

Verisante Provides Operational Update


2012 A FOUNDATION YEAR FOR THE INNOVATIVE, LIFE-SAVING SKIN CANCER DETECTOR AS IT READIES FOR MARKET LAUNCH VANCOUVER, BRITISH COLUMBIA - Verisante Technology, Inc. (TSX-V: VRS, OTCQX: VRSEF) (the “Company” or “Verisante”), a leader in cancer detection technology, provides a year-end wrap up and operational update. A summary of...

Full story

December 6, 2012 at 6:56 pm

Verisante Aura to be Displayed at Canada Science and Technology Museum


INNOVATIVE SKIN CANCER DETECTOR EXHIBITED IN “CURATOR’S CORNER” AND ACCEPTED INTO PERMANENT COLLECTION VANCOUVER, BRITISH COLUMBIA - Verisante Technology, Inc. (TSX-V: VRS, OTCQX: VRSEF) (the “Company” or “Verisante”), a leader in cancer detection technology, announced today that the early appearance model and sketches of the development of Verisante Aura™...

Full story

November 28, 2012 at 2:00 pm

Verisante Technology, Inc. Announces Study Results for Lung Cancer


NEW RESULTS ON 267 LESIONS IN LUNG CANCER STUDY SHOW VERISANTE CORE™  TO BE BEST IN CLASS VANCOUVER, BRITISH COLUMBIA - Verisante Technology, Inc. (TSX-V: VRS, OTCQX: VRSEF) (the “Company” or “Verisante”), a leader in cancer detection technology, announced today that the research team at the BC Cancer Agency...

Full story

November 22, 2012 at 2:00 pm

Verisante Featured on Business Television (BTV)


  VANCOUVER, BRITISH COLUMBIA - Verisante Technology, Inc. (TSX-V: VRS, OTC: VRSEF) (the “Company” or “Verisante”), a leader in cancer detection technology, announced today that the Company will be featured on Business Television (BTV) on November 24 and 25, 2012. BTV, a half-hour business program, has been...

Full story

November 20, 2012 at 7:54 pm

Verisante Aura Named Finalist for 2013 SPIE Prism Award


VANCOUVER, BRITISH COLUMBIA - Verisante Technology, Inc. (TSX-V: VRS, OTCQX: VRSEF, Frankfurt: V3T) (the “Company” or “Verisante”), a leader in cancer detection technology, announced today that Verisante’s Aura™, the revolutionary skin cancer detection device, has been named a finalist for the 2013 Prism Awards in the Life Sciences and Biophotonics...

Full story

November 8, 2012 at 2:00 pm

Verisante Technology, Inc. Issues Operational Update


  BETA UNITS IN CLINICS ACROSS CANADA, DISTRIBUTION SALES FORCE BEING TRAINED  VANCOUVER, BRITISH COLUMBIA - Verisante Technology, Inc. (TSX-V: VRS, OTCQX: VRSEF, Frankfurt: V3T) (the “Company” or “Verisante”), a leader in cancer detection technology, today issued an operational update on the commercialization of Verisante’s Aura™, the innovative...

Full story

September 19, 2012 at 2:00 pm

Verisante Technology, Inc. Announces Exclusive Distribution Agreement with BO-Pharma BV for Benelux Region


COMPANY TO ATTEND 21st CONGRESS OF THE EUROPEAN ACADEMY OF DERMATOLOGY IN PRAGUE, CZECH REPUBLIC VANCOUVER, BRITISH COLUMBIA - Verisante Technology, Inc. (TSX-V: VRS, OTCQX: VRSEF, Frankfurt: V3T) (the “Company” or “Verisante”), a leader in cancer detection technology, announced today that the Company has entered into an exclusive agreement with...

Full story

September 12, 2012 at 2:00 pm

Verisante Places Aura Beta Units For Safety, Verification Testing in B.C., Alberta and Ontario Clinics


CLINICAL USE TESTING FINAL STEP PRIOR TO MAKING NON-INVASIVE 
SKIN CANCER DETECTION DEVICE AVAILABLE IN APPROVED MARKETS VANCOUVER, BRITISH COLUMBIA - Verisante Technology, Inc. (TSX-V: VRS, OTCQX: VRSEF, Frankfurt: V3T) (the “Company” or “Verisante”), a leader in cancer detection technology, announced today that Aura™ Beta units continue to be...

Full story

September 10, 2012 at 2:00 pm

Verisante to Present at Rodman & Renshaw Annual Global Investment Conference


VANCOUVER, BRITISH COLUMBIA - Verisante Technology, Inc. (TSX-V: VRS, OTCQX: VRSEF, Frankfurt: V3T) (the “Company” or “Verisante”), a leader in cancer detection technology, announced today that Thomas Braun, the Company’s President and CEO will present at the Rodman & Renshaw 14th Annual Global Investment Conference which is being held at...

Full story

July 25, 2012 at 2:00 pm

Verisante Technology, Inc. Takes Delivery of Aura Devices from StarFish Medical Inc.


FIRST TWO PRE-PRODUCTION UNITS COMPLETED VANCOUVER, BRITISH COLUMBIA - Verisante Technology, Inc. (TSX-V: VRS, OTCQX: VRSEF, Frankfurt: V3T) (the “Company” or “Verisante”), a leader in cancer detection technology, announced today that the Company has accepted delivery of two initial pre-production units of the Verisante Aura™, an innovative skin cancer...

Full story

June 14, 2012 at 2:00 pm

Verisante Technology, Inc. Extends Research Agreement with BC Cancer Agency


  PLACES FIRST BETA UNITS AT THE VANCOUVER SKIN CARE CENTRE AND BC CANCER AGENCY VANCOUVER, BRITISH COLUMBIA - Verisante Technology, Inc. (TSX-V: VRS, OTCQX: VRSEF, Frankfurt: V3T) (the “Company” or “Verisante”), a leader in cancer detection technology, announced today that the Company has renewed its Collaborative Research...

Full story

June 6, 2012 at 2:00 pm

Verisante Technology, Inc. Exhibits at Leading Global and Canadian Radiation Technologist Events


CEO PRESENTS VERISANTE AURA AT THE CANADIAN INNOVATION SHOWCASE 
AT ISRRT WORLD CONGRESS AND CAMRT ANNUAL GENERAL CONFERENCE VANCOUVER, BRITISH COLUMBIA - Verisante Technology, Inc. (TSX-V: VRS, OTCQX: VRSEF, Frankfurt: V3T) (the “Company” or “Verisante”), a leader in cancer detection technology, announced today that Thomas Braun, the Company’s President...

Full story

May 8, 2012 at 2:00 pm

Verisante Technology, Inc. Announces Completion of Beta Units


EXPANDS PRODUCTION FACILITY, FILES YEAR-END FINANCIAL STATEMENTS VANCOUVER, BRITISH COLUMBIA - Verisante Technology, Inc. (TSX-V: VRS, OTCQX: VRSEF, Frankfurt: V3T) (the “Company” or “Verisante”), a leader in cancer detection technology, announced today that the Company has completed the design and fabrication of the beta version of Verisante Aura™. The...

Full story

April 5, 2012 at 2:00 pm

Verisante Chosen as “Pick of the Street” in the Technology and Life Sciences Sector


VANCOUVER, BRITISH COLUMBIA - Verisante Technology, Inc. (TSX-V: VRS, OTCQX: VRSEF, Frankfurt: V3T) (the “Company” or “Verisante”), a leader in cancer detection technology, announced today that the Company was named the “Pick of the Street” in the Technology and Life Sciences Sector of the TSX Venture Exchange. Following the...

Full story

April 3, 2012 at 4:00 pm

Verisante Opens the Market to Celebrate Top Ranking as Technology and Life Sciences Company


COMPANY ATTENDS TSX VENTURE 50 SPOTLIGHT EVENT AND PROVIDES OPERATIONAL UPDATE VANCOUVER, BRITISH COLUMBIA - Verisante Technology, Inc. (TSX-V: VRS, OTCQX: VRSEF, Frankfurt: V3T) (the “Company” or “Verisante”), a leader in cancer detection technology, announced today that president & CEO Thomas Braun will participate in the opening of the...

Full story

March 20, 2012 at 3:00 pm

Verisante Aura Clinical Study Results to be Published in ‘Cancer Research’


RESULTS CONCLUSIVELY DEMONSTRATE THE NON-INVASIVE SKIN CANCER DETECTOR'S DIAGNOSTIC ACCURACY AND POTENTIAL FOR REDUCING UNNECESSARY BIOPSIES VANCOUVER, BRITISH COLUMBIA - Verisante Technology, Inc. (TSX-V: VRS, OTCQX: VRSEF, Frankfurt: V3T) (the “Company” or “Verisante”), a leader in cancer detection technology, announced today that the results of the statistical analysis completed...

Full story

March 15, 2012 at 2:00 pm

Verisante Technology, Inc. Announces Exclusive Distribution Agreement with Clarion Medical Technologies Inc.


COMPANY TO ATTEND AMERICAN ACADEMY OF DERMATOLOGY’S 70TH ANNUAL MEETING IN SAN DIEGO, CALIFORNIA VANCOUVER, BRITISH COLUMBIA - Verisante Technology, Inc. (TSX-V: VRS, OTCQX: VRSEF, Frankfurt: V3T) (the “Company” or “Verisante”), a leader in cancer detection technology, announced today that the Company has entered into an exclusive agreement with...

Full story

February 15, 2012 at 2:05 pm

Verisante Technology, Inc. Named Top Technology and Life Sciences Company on the TSX Venture Top 50 2012 Ranking


  VANCOUVER, BRITISH COLUMBIA - Verisante Technology, Inc. (TSX-V: VRS, OTCQX: VRSEF, Frankfurt: V3T) (the “Company” or “Verisante”), a leader in cancer detection technology, announced today that the Company has been named this year’s top ranking Technology and Life Sciences Company on the TSX Venture 50.   The...

Full story

January 23, 2012 at 1:20 pm

Verisante Aura Clinical Study Data Analysis Presented at SPIE


Skin cancer detection device offers diagnostic accuracy, helps reduce biopsies VANCOUVER, BRITISH COLUMBIA - Verisante Technology, Inc. (TSX-V: VRS, OTCQX: VRSEF, Frankfurt: V3T) (the “Company” or “Verisante”), a leader in cancer detection technology, today announced the results of the statistical analysis completed by the University of British Columbia (“UBC”) on...

Full story

January 9, 2012 at 4:45 pm

Canadian Cancer Society names Verisante Core a Top 10 Cancer Breakthrough of 2011


VANCOUVER, BRITISH COLUMBIA - Verisante Technology, Inc. (TSX-V: VRS, OTCQX: VRSEF, Frankfurt: V3T) (the “Company” or “Verisante”), a leader in cancer detection technology, announced today that a research study using its Laser Raman Spectroscopy was named as one of the Canadian Cancer Society’s 10 research achievements for 2011.  "2011 has...

Full story

  Back to top